Vasomotor symptoms, often shortened to VMS, is the medical term for hot flashes (hot flushes) and night sweats. NICE, the guideline body for England, writes it as «vasomotor symptoms (hot flushes and sweats)»1, and The Menopause Society says hot flashes and night sweats are «also called vasomotor symptoms»2. The term appears in guidelines, medicine information and research papers, so it can turn up in a letter from your clinic too.
What are vasomotor symptoms?
Four health bodies use the term for the same two things:
- NICE lists «vasomotor symptoms (hot flushes and sweats)» among the symptoms linked to menopause1.
- The Menopause Society describes them as feelings of warmth that can come with flushing and sweating2.
- The US National Institute on Aging (NIA) says hot flashes and night sweats, «also called vasomotor symptoms», are among the most common symptoms of menopause3.
- The US Food and Drug Administration (FDA) describes them as feelings of warmth in the face, neck and chest, or sudden intense feelings of heat and sweating4.
NIA describes a hot flash as a sudden feeling of heat, most often in the upper body and face, and night sweats as hot flashes that occur during the night and may disrupt sleep3. For the sensations from start to finish, read what does a hot flash feel like?
Why are they called vasomotor?
NICE, The Menopause Society and NIA use the word on the pages cited here without explaining it1,2,3. Research papers fill the gap. MedlinePlus, from the US National Library of Medicine, defines a sister word, vasoconstriction, as the narrowing of blood vessels by small muscles in their walls5.
In a hot flash the vessels go the other way and dilate. A 2014 paper describes hot flashes as a rapid and exaggerated heat-loss response made of profuse sweating, peripheral vasodilation and feelings of intense internal heat6. A review of skin blood flow says that when the body heats up, blood vessels in the skin dilate and skin blood flow rises. It adds that hormone changes during menopause alter the control of skin blood flow, and that this might contribute to hot flashes7.
The explanation is incomplete. A review of findings from the US SWAN study says the physiology of hot flashes is not fully understood8. The guide on what causes hot flashes covers what the health bodies say about causes.
How common are vasomotor symptoms?
The Menopause Society says they occur in up to 80% of women during menopause2. In the Study of Women's Health Across the Nation (SWAN), which enrolled 3,302 midlife women, 60 to 80% had vasomotor symptoms at some point during the menopausal transition, and rates varied by racial and ethnic group8.
A SWAN analysis that followed 3,198 women from 1996 through 2002 found women reported vasomotor symptoms most often in late perimenopause and nearly as often in postmenopause9.
How long do vasomotor symptoms last?
A 2015 SWAN analysis looked at 1,449 women with frequent vasomotor symptoms, meaning hot flashes or night sweats on 6 or more days in the previous 2 weeks. The median total duration was 7.4 years. Among 881 women whose final period the study could observe, frequent symptoms continued for a median of 4.5 years after it10. The Menopause Society gives a mean of 7 to 10 years2.
A median is the middle value, so half the women had a shorter spell and half a longer one. How long do hot flashes last? goes through these figures in detail.
What counts as mild, moderate or severe VMS?
The phrase «moderate to severe vasomotor symptoms» appears in FDA medicine information and in a NICE recommendation1,4. The grading comes from drug research. In January 2003 the FDA published draft guidance for companies studying estrogen products. It says vasomotor symptoms in postmenopausal women «are commonly known as hot flushes or hot flashes» and defines their severity like this11:
| Grade | FDA definition |
|---|---|
| Mild | «sensation of heat without sweating» |
| Moderate | «sensation of heat with sweating, able to continue activity» |
| Severe | «sensation of heat with sweating, causing cessation of activity» |
The Menopause Society uses the same scale in plainer words: a mild hot flash may be a sensation of heat without sweating, and a severe one can bring enough heat and sweating that you have to stop what you are doing2.
The grade describes one hot flash. The count is a separate measure. For trials of treatments for moderate to severe vasomotor symptoms, the FDA draft recommends enrolling women who have «a minimum of 7 to 8 moderate to severe hot flushes per day, or 50 to 60 per week» at the start11. That number decides who enters a study. The guidance does not present it as a threshold for seeing a doctor or for being offered treatment. How many hot flashes a day is normal? looks at the counts.
Where you will see the term
- Guidelines. The NICE menopause guideline has a section headed «Vasomotor symptoms». It tells clinicians to offer HRT to people with vasomotor symptoms associated with menopause, and to consider menopause-specific cognitive behavioural therapy (CBT) as an option in addition to HRT, for people for whom HRT is contraindicated, or for those who prefer not to take it1.
- Identifying perimenopause. NICE says clinicians can identify perimenopause without laboratory tests in otherwise healthy women aged 45 or over who have vasomotor symptoms that started recently and any changes in their menstrual cycle1.
- Medicine information. The FDA draft guidance names «moderate to severe vasomotor symptoms associated with the menopause» as one of two symptom indications for estrogen therapy11. On its consumer page, the FDA describes an approved non-hormonal medicine as one used to reduce moderate to severe vasomotor symptoms due to menopause4.
- Research. Study titles and abstracts use VMS as shorthand. The SWAN paper on duration is titled «Duration of menopausal vasomotor symptoms over the menopause transition»10.
Which option suits you is a decision for you and your doctor or GP.
What to tell your doctor or GP about VMS
None of these sources lists the questions a doctor asks. They do show what trials and guidelines measure:
- How often. The FDA draft measures change in the frequency of hot flashes from the start of a study to week 4 and week 1211.
- How strong. It measures severity over the same weeks, and it accepts daily patient diary entries as a way to measure both11.
- Nights. NICE names night-time awakening as a sleep problem that comes with vasomotor symptoms1. See hot flashes at night.
- How much they bother you. NIA suggests noting what triggers your hot flashes and how much they bother you, because that can help you make better decisions about managing them12.
A record stays useful after you start a treatment. NICE tells clinicians to review each treatment for menopause symptoms at 3 months, then once a year unless there is a reason to review sooner1. How long does HRT take to work? covers that timeline.
A record that holds a daily count, a mild, moderate or severe mark for each hot flash, and the nights you woke covers the same measures. Bring it to your doctor or GP. The menopause symptom diary guide has a printable version. Meno, our iPhone journal, logs each hot flash with one tap, counts day and night apart, and puts the record on a one-page PDF for the appointment.
Common questions
Is VMS the same as hot flashes?
VMS covers hot flashes and night sweats together. The FDA draft guidance says vasomotor symptoms «are commonly known as hot flushes or hot flashes»11, and NICE adds sweats in its own wording1.
Are night sweats vasomotor symptoms?
Yes. NIA and The Menopause Society both name hot flashes and night sweats as vasomotor symptoms2,3. NIA describes night sweats as hot flashes that occur during the night3.
What counts as moderate to severe VMS?
In the FDA draft definitions, a moderate hot flash is a sensation of heat with sweating that lets you continue your activity, and a severe one makes you stop11. The draft recommends that trials enroll women who have at least 7 to 8 moderate to severe hot flashes a day11.
Sources
- NICE — Menopause: identification and management (NG23), Recommendations, published 12 November 2015, last updated 15 April 2026.
- The Menopause Society — Hot Flashes, accessed 16 November 2026.
- National Institute on Aging (NIH) — What Is Menopause?, content reviewed October 16, 2024.
- US Food and Drug Administration — Menopause, content current as of 12/14/2023.
- MedlinePlus (US National Library of Medicine) — Vasoconstriction, review date 1/1/2025.
- Freedman RR — Menopausal hot flashes: mechanisms, endocrinology, treatment, Journal of Steroid Biochemistry and Molecular Biology, 2014 Jul;142:115-20 (PubMed abstract).
- Charkoudian N — Skin blood flow in adult human thermoregulation: how it works, when it does not, and why, Mayo Clinic Proceedings, 2003 May;78(5):603-12 (PubMed abstract).
- Thurston RC, Joffe H — Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation, Obstetrics and Gynecology Clinics of North America, 2011 Sep;38(3):489-501 (full text on PubMed Central).
- Gold EB, Colvin A, Avis N, et al. — Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition, American Journal of Public Health, 2006 Jul;96(7):1226-35 (PubMed abstract).
- Avis NE, Crawford SL, Greendale G, et al. — Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Internal Medicine, 2015 Apr;175(4):531-9 (PubMed abstract).
- US Food and Drug Administration — Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms: Recommendations for Clinical Evaluation (draft guidance, PDF), January 2003.
- National Institute on Aging (NIH) — Hot Flashes: What Can I Do?, content reviewed September 30, 2021.
- NHS — Menopause and perimenopause symptoms, page last reviewed 19 May 2026.
